Antibodies specific for HeLa glycoprotein antigens are also specific for human endocervical epithelium. by Mujica van Herckenrode, C. et al.
Br. J. Cancer (1988), 57, 293-294 © The Macmillan Press Ltd., 1988
SHORT COMMUNICATION
Antibodies specific for HeLa glycoprotein antigens are also specific for
human endocervical epithelium
C. Mujica van Herckenrode1 2, D.J. Coleman1, M. Stanley3 & G.L.E. Koch4
'St Mary's Hospital Medical School, Paddington, London, UK; 2Department ofHistology, Faculty ofMedicine, University del
Pais Vasco, Jeioa, Viscaya, Spain; 3Department ofPathology, University of Cambridge, Cambridge; and 4Medical Research
Council Laboratory ofMolecular Biology, Hills Road, Cambridge CB2 2QH, UK.
The classification of tumour cells is one of the important
steps in the management of malignant disease (Neville et al.,
1982; Evans, 1983). Thus there is a continuing search for
markers which permit the accurate identification of the
normal cell(s) in tissues from which a particular malignancy
has arisen. There is a special need for such markers in the
case of cervical carcinomas since they can originate from any
of the three epithelial tissues, the endometrium, endocervix
or ectocervix (Blaustein, 1977). Distinguishing between these
could therefore be of considerable value.
It was previously shown (Koch & Smith, 1986) that
antibodies specific towards the HeLa cell line could be
produced by immunising rats with a specific glycoprotein
fraction derived from these cells. Preliminary studies
indicated that the antigens recognised are unique to the
endocervix, the tissue from which the original HeLa tumour
is thought to have originated (Jones et al., 1971). In this
study, we have examined the specificity of this antibody
systematically and show that it does indeed recognise
antigens on endocervical, but not on endometrial or
ectocervical cells.
Table I summarises the results of a study of 42 cervical
and endometrial biopsies carried out to systematically
evaluate the specificity of the antiserum. In 19 of the 23
examples of endocervical columnar epithelial cells, clear
positive staining was observed. In 9 of these it was very
intense, and in the rest moderate to weak. In only 4 cases
was there no staining whatsoever in any of the glands. It is
noteworthy that even in the samples which were positive, the
staining pattern was not uniform, since some glands were
clearly stained, whilst others showed no sign of staining.
Thus the 4 negative cases mentioned above could represent
extreme examples of this heterogeneity. The reason for this is
not known, but it could reflect variations in maturity of the
glandular cells, as has been observed elsewhere (Edwards,
1985). No staining was obtained with the six examples of
squamous and endometrial epithelium tested. However, 1 out
of 4 examples each of metaplastic epithelium and wart virus
specimens shows a weak positive reaction.
Of particular interest was the reactivity of the antiserum
towards premalignant lesions of the cervix. Seven examples
of CIN3 and two of CIN1-2 were examined; 6 were
negative, and in only one case of each was weak staining
observed. In glands covered partially by endocervical
columnar epithelium and partially by CIN3 epithelium, only
the columnar cells expressed the HeLa glycoprotein antigens.
It is generally accepted that the metaplastic epithelium and
the columnar epithelium have a common precursor. There is
also widespread agreement that the metaplastic epithelium of
the cervix is the target for malignant transformation and the
development of CIN (Blaustein, 1977). The implication is
that the pattern of antigens detected by the HeLa antiserum
are only expressed after the stem (precursor) cells are
committed to a columnar cell line.
The specific implication of these observations is that the
HeLa cell, in spite of prolonged culture in vitro, expresses
glycoprotein antigens expressed by the endocervical
epithelium from which the original tumour arose.
Furthermore, these antigens are not expressed by either the
endometrial or ectocervical epithelial cells. Thus they are of
potential value in the identification and classification of
endocervical tumour cells generally.
The general and more speculative implication of these
studies is that the use of glycoprotein immunogens from
cultured tumour cell lines could be of significant value in the
generation of novel antibodies, both polyclonal and
Table I Activity of a-HeLa polyclonal antibody on cervical and endometrial specimens
Strong Total Total
Histology Samples staining Moderate Weak positives negatives
Glandular endocervical epithelium 23 9 4 6 19 4
Original squamous epithelium 6 - - - - 6
Glandular endometrial epithelium 6 - - - 6
Squamous metaplastic epithelium 4 - - 1 1 3
Wart virus 4 - - 1 1 3
CIN 1-2 2 - - 1 1 1
CIN 3 7 - - 1 1 6
Endometrial hyperplasia adenocarcinoma 1 - - - - 1
Score assigned to the degrees of staining: Test sections and control sections were scored independently
(0-3), and the final score assigned to the test was obtained after subtraction of the control values. Biopsy
material was snap frozen and stored at -70°C until required. Sections (4-6pm) were placed on polylysine
coated glass slides, air dried, fixed in 5% formol saline and stained with an a-HeLa glycoprotein
antiserum (Koch & Smith, 1986) using an indirect immunoperoxidase technique (Heyderman, 1979).
Controls were carried out with non-immune rat serum.
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monoclonal, with specificity towards particular types of cells
and their derived tumours. Such antibodies could be of value
in immunocytochemical studies for tumour classification and
diagnosis (Gatter & Mason, 1982).
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